ARQULE INC (ARQL) has 159 open-market insider trades by 17 insiders since 2006. The most active filer is Timothy C. Barabe, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Biotechnology VALUE FUND L P | — | — | 4 | $25.9M | 2009-09-17 |
| Mark N. Lampert | 10% | — | 1 | $22.9M | 2010-04-01 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | — | 4 | $16.4M | 2018-04-18 |
| BVF Partners L P/il | 10% Owner | — | 4 | $15.2M | 2018-04-04 |
| BVF Investments LLC | — | — | 5 | $9.7M | 2008-11-12 |
| BVF Inc/il | 10% | — | 5 | $7.3M | 2010-04-05 |
| Ran Nussbaum | Dir | — | 3 | $5.6M | 2020-01-16 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | 10% Owner | — | 1 | $5.2M | 2018-05-30 |
| Michael D. Loberg | Dir | — | 43 | $387K | 2020-01-16 |
| Paolo Pucci | CEO | — | 20 | $307K | 2020-01-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ran Nussbaum | Director | Buy | $4.1M | 2019-06-27 |
| Ran Nussbaum | Director | Buy | $1.5M | 2018-07-13 |
| Biotechnology Value Trading Fund OS LP | 10% Owner | Sell | $5.2M | 2018-05-30 |
| Ran Nussbaum | Director | Buy | $28K | 2018-05-18 |
| Paolo Pucci | CEO | Buy | $51K | 2018-05-18 |
| Patrick J. Zenner | Director | Buy | $25K | 2018-05-14 |
Companies that share insiders with ARQL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ronald M. Lindsay | Director | Buy | $19K | 2018-05-11 |
| Ronald M. Lindsay | Director | Buy | $64K | 2018-05-10 |
| Paolo Pucci | CEO | Buy | $3K | 2018-05-10 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | Sell | $13.8M | 2018-04-18 |
| BVF Partners L P/il | 10% Owner | Sell | $13.3M | 2018-04-04 |
| Paolo Pucci | CEO | Buy | $1K | 2017-09-07 |
| Paolo Pucci | CEO | Buy | $19K | 2017-09-06 |
| Paolo Pucci | CEO | Buy | $22K | 2017-09-05 |
| Paolo Pucci | CEO | Buy | $315 | 2017-08-29 |